Who is sponsoring NCT04962763?

NCT04962763 is sponsored by Peking University Third Hospital.

What condition does NCT04962763 study?

NCT04962763 studies To Search for Biomarkers Associated With Ischemic Heart Failure, To Explore the Relationship Between Intestinal Flora and Ischemic Heart Failure.

Is NCT04962763 still recruiting?

NCT04962763 is currently status unknown. Last updated 15 July 2021.

Last reviewed 2021-07-15 · How we verify

NCT04962763

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Correlation of Intestinal Flora and Metabolomics in Patients With Ischemic Heart Failure

Status unknown Last updated 15 July 2021

What this trial tests

trial in To Search for Biomarkers Associated With Ischemic Heart Failure in 200 participants. Status unknown.

Timeline

30 June 2021

Primary endpoint
30 May 2022

30 April 2023

Quick facts

Lead sponsor	Peking University Third Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	200
Start date	30 June 2021
Primary completion	30 May 2022
Estimated completion	30 April 2023
Sites	1 location across China

Conditions studied

To Search for Biomarkers Associated With Ischemic Heart Failure — all drugs for To Search for Biomarkers Associated With Ischemic Heart Failure →
To Explore the Relationship Between Intestinal Flora and Ischemic Heart Failure — all drugs for To Explore the Relationship Between Intestinal Flora and Ischemic Heart Failure →

Sponsor

Peking University Third Hospital

Who can join

Adults 18 to 90, any sex, with To Search for Biomarkers Associated With Ischemic Heart Failure or To Explore the Relationship Between Intestinal Flora and Ischemic Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To provide new ideas for the treatment of patients with ischemic heart failure, this study is to search for differential metabolic markers associated with ischemic heart failure and to study the influence of fecal flora on the course of heart failure in patients with ischemic heart failure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Peking University Third Hospital trials

Trials by the same sponsor.

NCT07532421 — Probiotic Intervention on the Development of Allergic Diseases in Infants Exposed to Antibiotics Early in Life · NA · not yet recruiting
NCT07470255 — Detection of Diabetic Foot Skin Damage Using Plantar Mechanical Parameters · not yet recruiting
NCT07453381 — Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective · not yet recruiting
NCT07452354 — AI-Based Diabetic Foot Recurrence Cohort · not yet recruiting
NCT07423819 — Sports Rehabilitation Therapy for Knee Joint Sports Injuries: A Case Study of Anterior Cruciate Ligament Injury and Pate · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04962763 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peking University Third Hospital
Last refreshed: 15 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04962763.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing